Drug price watchdog ICER dives into Trump fueled pharma rebate debate

13 March 2019 - With public and political winds blowing in the same direction, significant reform of the complicated U.S. ...

Read more →

Institute for Clinical and Economic Review publishes white paper on alternative models for pharmaceutical rebates

12 March 2019 - Paper explores how reforming or eliminating rebates may affect drug pricing, patient access, and incentives for future ...

Read more →